Eds Ultrasonic TIPS
Essential Dental Systems
FDA Clearance Information
The EDS Ultrasonic Tips were cleared through the FDA 510(k) pathway on January 22, 2014. Manufactured by Essential Dental Systems, they are classified as Class 2 devices.
What It Is
FDA-Cleared Indications
- Use as ultrasonic tips during dental procedures to assist with cleaning and decontamination of dental implant surfaces.
- Use in procedures involving the removal of bacterial biofilm and other contaminants from dental implants.
Clinical Applications
- Ultrasonic decontamination of dental implant surfaces.
- Removal of bacterial biofilm from dental implants during peri-implant disease treatment.
- Removal of surface contaminants from dental implants as part of implant maintenance or treatment.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The tips are intended for use with compatible ultrasonic dental equipment; compatibility should be confirmed before treatment.
- Tip size and shape should be selected according to the implant design, surface access and treatment area.
- Use requires careful technique to avoid unwanted damage to the implant surface or surrounding tissues.
- The FDA record identifies the device as a Class II 510(k)-cleared dental device; it is not an MRI implant or an implanted device.
- Contraindications, sterilization requirements and reuse limitations should be taken from the current manufacturer instructions for use.
Frequently Asked Questions
What are the clinical indications for EDS Ultrasonic Tips?
EDS Ultrasonic Tips are indicated for the decontamination of dental implant surfaces, particularly in the treatment of peri-implantitis.
What outcomes have been reported in clinical studies?
Studies report effective decontamination of implant surfaces with EDS Ultrasonic Tips, maintaining surface integrity while removing contaminants.
What complications have been reported?
Safety data indicate the potential release of titanium particles during use, which could lead to inflammation, but no major adverse events have been reported.